Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01609114|
Recruitment Status : Unknown
Verified May 2013 by Far Eastern Memorial Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 31, 2012
Last Update Posted : May 10, 2013
The concurrent use of chemotherapy during radiation therapy (CCRT) is now the important treatment stratagem for locally advanced head and neck cancer or nasopharyngeal cancer (NPC). For these cases, 5-Fluorouracil (5-FU) and cisplatin (CDDP) are the most commonly used agents of CCRT. It plays an important role to improve the treatment outcome and increases the opportunities for organ preservation.
In the past, Radiotherapy (RT) was solely used as a local treatment and its effect was estimated by local effect model. However, growing evidence shows that irradiation has direct DNA damage-dependent effects as well as sending signals to neighboring cells. Recently, the investigators reported that abdominal irradiation could significantly modulate the systemic pharmacokinetics of 5-FU at 0.5 Gy, off-target area in clinical practice, and at 2 Gy, the daily treatment dose for target treatment in an experimental rat model. Additionally, the results from a clinical investigation showed that colorectal cancer patients with lower AUC of 5-FU during adjuvant chemotherapy had lower disease-free survival. Taken together, these lines of evidence support the importance and necessity to search for the mediators responsible for the unexpected effect of local RT on systemic pharmacokinetics of chemotherapeutic agents, such as 5-FU.
In the present study, the investigators examined whether the phenomena and mechanism of RT-PK(pharmacokinetics) is a fact for different anticancer drugs and for different part in human.
|Condition or disease|
|Head and Neck Cancer|
|Study Type :||Observational|
|Actual Enrollment :||30 participants|
|Observational Model:||Case Control|
|Official Title:||Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||July 2016|
chemotherapy (C/T) is applied in the morning. After 4-6 hrs, RT is delivered (according to the clinical practice).
RT is delivered in the morning. After 4-6 hrs, C/T is applied.
- Area under the plasma concentration versus time curve (AUC) of'chemo-drugs" [ Time Frame: "15, 30, 45, 60, 90, 120 min post‐dose" ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01609114
|Far Eastern Memorial Hospital|
|New Taipei city, Taiwan, 220|